Bing Zhao

Prof. Dr. Bing Zhao

Anhui Medical University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2016 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
CMChun-Chun Ma
Chun-Chun Ma
ZXZhang Xiong
Zhang Xiong
GZGuan-Nan Zhu
Guan-Nan Zhu
CWChao Wang
Chao Wang
GZGang Zong
Gang Zong
BZBing Zhao
Bing Zhao
Glioma is one of the most common and aggressive primary malignant tumor in the brain. Accumulating evidences indicated that aberrantly expressed non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), contribute to tumorigenesis. However, potential mechanisms between lncRNAs and miRNAs in glioma remain largely unknown. Long non-coding RNA activated by TGF-β (LncRNA-ATB) expression in glioma tissues and cells was quantified by quantitative reverse transcription–PCR. Glioma cell lines U251 and A172 were transfected with sh-ATB, miR-200a mimics, miR-200a inhibitors, after we assayed the cell phenotype and expression of the relevant molecules. Dual-luciferase reporter assay, RIP and a xenograft mouse model were used to examine the expression of sh-ATB and its target gene miR-200a. ATB is abnormally up-regulated both in glioma tissues and cell lines compared with normal brain tissues, and glioma patients with high ATB expression had shorter overall survival time. Knockdown of ATB significantly inhibits glioma malignancy, including cell proliferation, colony formation, migration, invasion in vitro, and the xenograft tumor formation in vivo. In addition, ATB was confirmed to target miR-200a, and miR-200a inhibition reversed the malignant characteristics of ATB knockdown on glioma cells. In particular, ATB may act as a ceRNA, effectively becoming a sink for miR-200a, thereby modulating the derepression of TGF-β2. Our findings suggest that ATB plays an oncogenic role of glioma cells by inhibiting miR-200a and facilitating TGF-β2 in glioma, thereby may represent a potential therapeutic target for the treatment of human glioma.

10 December 2015 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
JLJia Li
Jia Li
EBEr-Bao Bian
Er-Bao Bian
XHXiao-Jun He
Xiao-Jun He
CMChun-Chun Ma
Chun-Chun Ma
GZGang Zong
Gang Zong
BZBing Zhao
Bing Zhao
Epigenetic regulation plays a significant role in gliomas. However, how methylation and long non-coding RNA (lncRNA) cooperates to regulate gliomas progression is largely unknown. In this investigation we showed that the downregulation of MEG3 expression due to hypermethylation of MEG3 was observed in gliomas tissues. Treatment of glioma cells with the DNA methylation inhibitor 5-Aza-2'-deoxycytidine (5-AzadC) decreased aberrant hypermethylation of the MEG3 promoter and prevented the loss of MEG3 expression. In addition, DNMT1 was involved in MEG3 promoter methylation, and was inversely correlated with MEG3 expression in gliomas. The inhibition of DNMT1 repressed the proliferation, clone formation, and induced apoptosis in glioma cells. Importantly, the inhibition of DNMT1 contributed to the activation of p53 pathways in gliomas cells. These results suggest that DNMT1-mediated MEG3 hypermethylation caused the loss of MEG3 expression, followed by the inhibition of the p53 pathways in gliomas.

29 May 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
FTFeng Tang
Feng Tang
HWHongliang Wang
Hongliang Wang
ECErfeng Chen
Erfeng Chen
EBErbao Bian
Erbao Bian
YXYadi Xu
Yadi Xu
BZBing Zhao
Bing Zhao

21 April 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
EBEr-Bao Bian
Er-Bao Bian
CMChun-Chun Ma
Chun-Chun Ma
XHXiao-Jun He
Xiao-Jun He
CWChao Wang
Chao Wang
GZGang Zong
Gang Zong
BZBing Zhao
Bing Zhao
Epigenetic modification of miR-141 regulates SKA2 by an endogenous ‘sponge’ HOTAIR in glioma

25 October 2021 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
EBErbao Bian
Erbao Bian
XCXueran Chen
Xueran Chen
LCLi Cheng
Li Cheng
MCMeng Cheng
Meng Cheng
ZCZhigang Chen
Zhigang Chen
JLJun Li
Jun Li
Background: Long non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression. Methods: RNA sequencing (RNA-seq) and quantitative real-time PCR were performed to screen differentially expressed genes. CCK-8, transwell migration, invasion assays, and a mouse xenograft model were performed to determine the functions of TMEM44-AS1. Co-IP, ChIP, Dual-luciferase reporter assays, RNA pulldown, and RNA immunoprecipitation assays were performed to study the molecular mechanism of TMEM44-AS1 and the downstream target. Results: We identified a novel lncRNA TMEM44-AS1, which was aberrantly expressed in glioma tissues, and that increased TMEM44-AS1 expression was correlated with malignant progression and poor survival for patients with glioma. Expression of TMEM44-AS1 increased the proliferation, colony formation, migration, and invasion of glioma cells. Knockdown of TMEM44-AS1 in glioma cells reduced cell proliferation, colony formation, migration and invasion, and tumor growth in a nude mouse xenograft model. Mechanistically, TMEM44-AS1 is directly bound to the SerpinB3, and sequentially activated Myc and EGR1/IL-6 signaling; Myc transcriptionally induced TMEM44-AS1 and directly bound to the promoter and super-enhancer of TMEM44-AS1, thus forming a positive feedback loop with TMEM44-AS. Further studies demonstrated that Myc interacts with MED1 regulates the super-enhancer of TMEM44-AS1. More importantly, a novel small-molecule Myc inhibitor, Myci975, alleviated TMEM44-AS1-promoted the growth of glioma cells. Conclusions: Our study implicates a crucial role of the TMEM44-AS1-Myc axis in glioma progression and provides a possible anti-glioma therapeutic agent.

9 January 2014 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
EBEr‐Bao Bian
Er‐Bao Bian
JLJia Li
Jia Li
YXYong‐Sheng Xie
Yong‐Sheng Xie
GZGang Zong
Gang Zong
JLJun Li
Jun Li
BZBing Zhao
Bing Zhao